Aurobindo Pharma completes ₹800 crore share buyback
Aurobindo Pharma completed its share buyback of 54,23,728 shares at ₹1,475 each for ₹800 crore, representing 3.93% of its equity capital. The buyback was conducted from 23 to 29 April 2026, enhancing shareholder value.
after close1 source ↓written by the desknot a recommendation
- its buyback
- 54,23,728 equity shares
- per share
- ₹1,475
- totaling
- ₹800 crore
- of its paid-up
- 3.93%
- and concluded
- 17 Apr 2026
Aurobindo Pharma has successfully completed its buyback of 54,23,728 equity shares at ₹1,475 per share, totaling ₹800 crore. This buyback, conducted via a tender offer, represents 3.93% of its paid-up equity capital.
The buyback was initiated on 17 Apr 2026 and concluded on 29 Apr 2026, aligning with SEBI regulations. This move may enhance shareholder value and improve earnings per share.
Not investment advice. For informational purposes only.